Correction to: Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease (Clinical and Experimental Nephrology, (2023), 27, 10, (809-818), 10.1007/s10157-023-02372-8)

Hiroshi Kataoka, Yosuke Shimada, Tomonori Kimura, Saori Nishio, Shinya Nakatani, Toshio Mochizuki, Ken Tsuchiya, Junichi Hoshino, Fumihiko Hattanda, Haruna Kawano, Kazushige Hanaoka, Sumi Hidaka, Daisuke Ichikawa, Eiji Ishikawa, Kiyotaka Uchiyama, Hiroki Hayashi, Shiho Makabe, Shun Manabe, Michihiro Mitobe, Akinari SekineTatsuya Suwabe, Hirayasu Kai, Mahiro Kurashige, Koichi Seta, Keiji Shimazu, Tomofumi Moriyama, Mai Sato, Tadashi Otsuka, Kan Katayama, Wataru Shimabukuro, Takuya Fujimaru, Kenichiro Miura, Koichi Nakanishi, Shigeo Horie, Kengo Furuichi, Hirokazu Okada, Ichiei Narita, Satoru Muto

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the original publication, the third author Tomonori Kimura was inadvertently missed to include in the author group. The author's affiliation details are as follows: Tomonori Kimura Reverse Translational Research Project, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki, Osaka, Japan The original article has been corrected.

Original languageEnglish
Pages (from-to)82-83
Number of pages2
JournalClinical and Experimental Nephrology
Volume28
Issue number1
DOIs
Publication statusPublished - 01-2024

All Science Journal Classification (ASJC) codes

  • Physiology
  • Nephrology
  • Physiology (medical)

Fingerprint

Dive into the research topics of 'Correction to: Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease (Clinical and Experimental Nephrology, (2023), 27, 10, (809-818), 10.1007/s10157-023-02372-8)'. Together they form a unique fingerprint.

Cite this